Equity Profile

A

Agilent Technologies, Inc.

Health CareLife Sciences Tools & Services$38.3B

Aug26Wed

Pre-Earnings Brief

UpcomingQ3-2026After Close5:00 PM EDT

Company Snapshot

Agilent Technologies, Inc. is a leading player in the health care sector, specializing in life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well Agilent is managing its costs and generating income.

Expected to be around $1.49

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market share and drive future profits.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

A Q3-2026 Earnings Preview

Context

Company Snapshot

Agilent Technologies, Inc. is a leading player in the health care sector, specializing in life sciences tools and services. The company provides critical technologies and solutions that support research and development in various scientific fields, making it essential for advancements in health care and biotechnology.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.40%

Avg Stock Reaction

+0.42%

Last Quarter Recap

In Q2 2026, Agilent reported an EPS of $1.49, exceeding expectations by 6.2%. The stock saw a modest increase of 0.66% the following day, reflecting a positive market reaction.

Management Promises & Guidance

Focus on expanding product offerings in life sciences.
Commitment to improving operational efficiencies.
Plans to enhance customer engagement through technology.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Agilent's upcoming earnings, given the company's recent EPS beats. However, uncertainty remains due to the lack of revenue guidance.

Bull Case

If Agilent continues its trend of beating EPS estimates, it could signal strong underlying demand and operational efficiency, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, especially given the high implied volatility.

Key Metrics to Watch

Earnings Per Share (EPS)

Expected to be around $1.49

EPS is a key indicator of profitability and will show how well Agilent is managing its costs and generating income.

Revenue Growth

Not available

Revenue growth is crucial for assessing the company's ability to expand its market share and drive future profits.

Gross Margin

Not available

Gross margin indicates the efficiency of production and pricing strategies, which is vital for maintaining profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q3-2026?

This will be a crucial indicator of Agilent's profitability and could significantly impact investor sentiment.

How is Agilent addressing potential supply chain challenges?

Supply chain issues could affect production and revenue, making this a key area of focus for investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Agilent's ability to leverage new technologies for growth, particularly in the life sciences sector.

Supporting Evidence

Agilent has a strong track record of beating EPS estimates, suggesting operational resilience.

Recent trends in life sciences spending indicate a potential uptick in demand that may not be fully reflected in current estimates.

Key Risk

If Agilent's EPS comes in below $1.40, it could undermine confidence in its growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around Agilent's ability to maintain its earnings momentum amidst potential market challenges.

Bull Confirmed If

An EPS of $1.55 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $1.40 would raise concerns about profitability and market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±8.07%

Historical Avg

±0.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect either strong positive or negative news following the earnings report.

Options are pricing ±8.1% while A has averaged ±0.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

56.2%

Calls (1.0M)P/C Ratio: 1.30Puts (345K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Agilent beats expectations, history suggests the stock could rise by about 0.46%, confirming strong demand and operational strength.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a decline of around 0.29%, reflecting disappointment and concerns over future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in the life sciences segment.
2Management's commentary on supply chain management and its impact on operations.
3Insights into customer demand trends and market expansion strategies.
4Details on cost management initiatives and their effect on margins.
5Any guidance on future revenue expectations or market conditions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Sandisk Corporation

Company Snapshot

Agilent Technologies, Inc. is a leading player in the health care sector, specializing in life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well Agilent is managing its costs and generating income.

Expected to be around $1.49

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market share and drive future profits.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

A Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.40%

Avg Stock Reaction

+0.42%

Last Quarter Recap

In Q2 2026, Agilent reported an EPS of $1.49, exceeding expectations by 6.2%. The stock saw a modest increase of 0.66% the following day, reflecting a positive market reaction.

Management Promises & Guidance

Focus on expanding product offerings in life sciences.
Commitment to improving operational efficiencies.
Plans to enhance customer engagement through technology.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Agilent's upcoming earnings, given the company's recent EPS beats. However, uncertainty remains due to the lack of revenue guidance.

Bull Case

If Agilent continues its trend of beating EPS estimates, it could signal strong underlying demand and operational efficiency, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, especially given the high implied volatility.

Key Metrics to Watch

Earnings Per Share (EPS)

Expected to be around $1.49

EPS is a key indicator of profitability and will show how well Agilent is managing its costs and generating income.

Revenue Growth

Not available

Revenue growth is crucial for assessing the company's ability to expand its market share and drive future profits.

Gross Margin

Not available

Gross margin indicates the efficiency of production and pricing strategies, which is vital for maintaining profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q3-2026?

This will be a crucial indicator of Agilent's profitability and could significantly impact investor sentiment.

How is Agilent addressing potential supply chain challenges?

Supply chain issues could affect production and revenue, making this a key area of focus for investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Agilent's ability to leverage new technologies for growth, particularly in the life sciences sector.

Supporting Evidence

Agilent has a strong track record of beating EPS estimates, suggesting operational resilience.

Recent trends in life sciences spending indicate a potential uptick in demand that may not be fully reflected in current estimates.

Key Risk

If Agilent's EPS comes in below $1.40, it could undermine confidence in its growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around Agilent's ability to maintain its earnings momentum amidst potential market challenges.

Bull Confirmed If

An EPS of $1.55 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $1.40 would raise concerns about profitability and market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±8.07%

Historical Avg

±0.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect either strong positive or negative news following the earnings report.

Options are pricing ±8.1% while A has averaged ±0.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

56.2%

Calls (1.0M)P/C Ratio: 1.30Puts (345K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Agilent beats expectations, history suggests the stock could rise by about 0.46%, confirming strong demand and operational strength.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a decline of around 0.29%, reflecting disappointment and concerns over future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in the life sciences segment.
2Management's commentary on supply chain management and its impact on operations.
3Insights into customer demand trends and market expansion strategies.
4Details on cost management initiatives and their effect on margins.
5Any guidance on future revenue expectations or market conditions.